论文部分内容阅读
目的:探讨血管紧张素转化酶抑制剂进行治疗充血性心力衰竭的效果。方法:选取2014~2015年入住我院治疗充血性心力衰竭的患者74例,随机分为A、B两组,A组32例患者使用一般性治疗方式,B组42例患者在A组治疗方式的基础上使用血管紧张素转化酶抑制剂,在两组接受治疗的前后观测心率,同时开展6min步行测试,检查血压、LVEF、LVDD及心功能等信息监测记录,最终进行对比。结果:B组在治疗之后,充血性心力衰竭症状明显好转,心率渐缓,血压降低,其他各项检测指标也都呈现出好转趋势,且心功能好转明显,B组的整体有效率明显好于A组(P均<0.05)。结论:在治疗充血性心力衰竭的过程中,使用血管紧张素转化酶抑制剂能够明显让心脏功能好转,降低死亡率,减慢心室重塑进程,减少心力衰竭导致的死亡病例,安全可靠,可以推广。
Objective: To investigate the effect of angiotensin converting enzyme inhibitor in the treatment of congestive heart failure. Methods: A total of 74 patients admitted to our hospital from 2014 to 2015 for treatment of congestive heart failure were randomly divided into A and B groups, 32 patients in group A received general treatment, and 42 patients in group B received treatment in group A Based on the use of angiotensin-converting enzyme inhibitors in both groups before and after treatment to observe heart rate, at the same time carry out 6min walk test, check the blood pressure, LVEF, LVDD and heart function monitoring records, and finally for comparison. Results: In group B, the symptoms of congestive heart failure improved obviously, heart rate gradually decreased, blood pressure decreased, and other test indicators also showed a tendency of improvement, and the improvement of cardiac function was obvious. The overall effective rate of group B was significantly better than that of group B Group A (all P <0.05). Conclusion: In the treatment of congestive heart failure, the use of angiotensin-converting enzyme inhibitors can significantly improve cardiac function, reduce mortality, slow the process of ventricular remodeling, reduce heart failure caused by deaths, safe and reliable, you can Promotion.